Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | -4.66% |
| 2022 | 1.2 Billion USD | -1.74% |
| 2021 | 1.22 Billion USD | 37.39% |
| 2020 | 889.3 Million USD | 3.43% |
| 2019 | 859.8 Million USD | 166.52% |
| 2018 | 322.6 Million USD | -22.38% |
| 2017 | 415.6 Million USD | 6.13% |
| 2016 | 391.6 Million USD | 47.22% |
| 2015 | 266 Million USD | -24.9% |
| 2014 | 354.2 Million USD | -0.03% |
| 2013 | 354.3 Million USD | 5.48% |
| 2012 | 335.9 Million USD | 53.1% |
| 2011 | 219.4 Million USD | 153.35% |
| 2010 | 86.6 Million USD | -25.15% |
| 2009 | 115.7 Million USD | -36.71% |
| 2008 | 182.8 Million USD | 2758.93% |
| 2007 | 6.39 Million USD | -72.03% |
| 2006 | 22.86 Million USD | 6.72% |
| 2005 | 21.42 Million USD | -22.84% |
| 2004 | 27.76 Million USD | 5.27% |
| 2003 | 26.37 Million USD | 228.12% |
| 2002 | 8.03 Million USD | -29.01% |
| 2001 | 11.32 Million USD | -5.93% |
| 2000 | 12.03 Million USD | -6.28% |
| 1999 | 12.84 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 2.26 Billion USD | 6.21% |
| 2024 Q1 | 1.35 Billion USD | 18.59% |
| 2024 Q2 | 2.13 Billion USD | 57.08% |
| 2023 Q2 | 1.12 Billion USD | 1.22% |
| 2023 FY | 1.14 Billion USD | -4.66% |
| 2023 Q1 | 1.1 Billion USD | -7.62% |
| 2023 Q3 | 1.09 Billion USD | -2.13% |
| 2023 Q4 | 1.14 Billion USD | 4.18% |
| 2022 Q4 | 1.2 Billion USD | 5.6% |
| 2022 FY | 1.2 Billion USD | -1.74% |
| 2022 Q1 | 1.2 Billion USD | -1.34% |
| 2022 Q2 | 1.17 Billion USD | -2.85% |
| 2022 Q3 | 1.13 Billion USD | -2.92% |
| 2021 Q4 | 1.22 Billion USD | 70.29% |
| 2021 FY | 1.22 Billion USD | 37.39% |
| 2021 Q2 | 721.1 Million USD | 0.74% |
| 2021 Q3 | 717.5 Million USD | -0.5% |
| 2021 Q1 | 715.8 Million USD | -19.51% |
| 2020 Q2 | 966.6 Million USD | 0.78% |
| 2020 Q1 | 959.1 Million USD | 11.55% |
| 2020 Q3 | 870.3 Million USD | -9.96% |
| 2020 Q4 | 889.3 Million USD | 2.18% |
| 2020 FY | 889.3 Million USD | 3.43% |
| 2019 Q1 | 390.3 Million USD | 20.99% |
| 2019 Q4 | 859.8 Million USD | 51.05% |
| 2019 Q3 | 569.2 Million USD | 3.62% |
| 2019 FY | 859.8 Million USD | 166.52% |
| 2019 Q2 | 549.3 Million USD | 40.74% |
| 2018 FY | 322.6 Million USD | -22.38% |
| 2018 Q2 | 205.6 Million USD | 0.0% |
| 2018 Q3 | 225.2 Million USD | 9.53% |
| 2018 Q4 | 322.6 Million USD | 43.25% |
| 2018 Q1 | 205.6 Million USD | -50.53% |
| 2017 Q3 | 480.5 Million USD | 11.56% |
| 2017 FY | 415.6 Million USD | 6.13% |
| 2017 Q4 | 415.6 Million USD | -13.51% |
| 2017 Q1 | 384.7 Million USD | -1.76% |
| 2017 Q2 | 430.7 Million USD | 11.96% |
| 2016 FY | 391.6 Million USD | 47.22% |
| 2016 Q2 | 322.7 Million USD | 14.51% |
| 2016 Q3 | 344.7 Million USD | 6.82% |
| 2016 Q1 | 281.8 Million USD | 5.94% |
| 2016 Q4 | 391.6 Million USD | 13.61% |
| 2015 Q2 | 241.4 Million USD | -31.79% |
| 2015 Q4 | 266 Million USD | 10.33% |
| 2015 Q3 | 241.1 Million USD | -0.12% |
| 2015 FY | 266 Million USD | -24.9% |
| 2015 Q1 | 353.9 Million USD | -0.08% |
| 2014 Q2 | 354.9 Million USD | 0.23% |
| 2014 Q4 | 354.2 Million USD | -0.08% |
| 2014 Q3 | 354.5 Million USD | -0.11% |
| 2014 Q1 | 354.1 Million USD | -0.06% |
| 2014 FY | 354.2 Million USD | -0.03% |
| 2013 Q2 | 335.4 Million USD | -0.03% |
| 2013 Q3 | 354.7 Million USD | 5.75% |
| 2013 FY | 354.3 Million USD | 5.48% |
| 2013 Q1 | 335.5 Million USD | -0.12% |
| 2013 Q4 | 354.3 Million USD | -0.11% |
| 2012 Q3 | 298 Million USD | 22.48% |
| 2012 FY | 335.9 Million USD | 53.1% |
| 2012 Q2 | 243.3 Million USD | 0.0% |
| 2012 Q4 | 335.9 Million USD | 12.72% |
| 2012 Q1 | 243.3 Million USD | 10.89% |
| 2011 FY | 219.4 Million USD | 153.35% |
| 2011 Q3 | 40.8 Million USD | -32.23% |
| 2011 Q2 | 60.2 Million USD | -23.8% |
| 2011 Q1 | 79 Million USD | -8.78% |
| 2011 Q4 | 219.4 Million USD | 437.75% |
| 2010 Q1 | 109.6 Million USD | -5.27% |
| 2010 FY | 86.6 Million USD | -25.15% |
| 2010 Q4 | 86.6 Million USD | -8.17% |
| 2010 Q3 | 94.3 Million USD | -7.19% |
| 2010 Q2 | 101.6 Million USD | -7.3% |
| 2009 Q1 | 172.7 Million USD | -5.53% |
| 2009 Q4 | 115.7 Million USD | -3.9% |
| 2009 Q3 | 120.4 Million USD | -5.64% |
| 2009 FY | 115.7 Million USD | -36.71% |
| 2009 Q2 | 127.6 Million USD | -26.11% |
| 2008 Q1 | 169.42 Million USD | 2549.8% |
| 2008 Q3 | 169.7 Million USD | -3.42% |
| 2008 Q4 | 182.8 Million USD | 7.72% |
| 2008 Q2 | 175.71 Million USD | 3.71% |
| 2008 FY | 182.8 Million USD | 2758.93% |
| 2007 Q3 | 18.07 Million USD | 2.93% |
| 2007 Q2 | 17.56 Million USD | -22.9% |
| 2007 FY | 6.39 Million USD | -72.03% |
| 2007 Q1 | 22.78 Million USD | -0.35% |
| 2007 Q4 | 6.39 Million USD | -64.63% |
| 2006 FY | 22.86 Million USD | 6.72% |
| 2006 Q4 | 22.86 Million USD | -15.39% |
| 2006 Q3 | 27.02 Million USD | 23.0% |
| 2006 Q2 | 21.96 Million USD | 2.79% |
| 2006 Q1 | 21.37 Million USD | -0.24% |
| 2005 Q1 | 26.26 Million USD | -5.4% |
| 2005 Q2 | 23.91 Million USD | -8.96% |
| 2005 FY | 21.42 Million USD | -22.84% |
| 2005 Q4 | 21.42 Million USD | -1.82% |
| 2005 Q3 | 21.82 Million USD | -8.74% |
| 2004 FY | 27.76 Million USD | 5.27% |
| 2004 Q1 | 26.16 Million USD | -0.8% |
| 2004 Q2 | 26.84 Million USD | 2.61% |
| 2004 Q3 | 27.1 Million USD | 0.97% |
| 2004 Q4 | 27.76 Million USD | 2.43% |
| 2003 Q1 | 8.43 Million USD | 4.99% |
| 2003 Q4 | 26.37 Million USD | 0.13% |
| 2003 Q3 | 26.33 Million USD | 210.31% |
| 2003 Q2 | 8.48 Million USD | 0.58% |
| 2003 FY | 26.37 Million USD | 228.12% |
| 2002 Q2 | 12.66 Million USD | 13.91% |
| 2002 Q1 | 11.12 Million USD | -1.78% |
| 2002 FY | 8.03 Million USD | -29.01% |
| 2002 Q4 | 8.03 Million USD | -35.9% |
| 2002 Q3 | 12.54 Million USD | -1.01% |
| 2001 Q3 | 11.62 Million USD | 7.13% |
| 2001 FY | 11.32 Million USD | -5.93% |
| 2001 Q4 | 11.32 Million USD | -2.61% |
| 2001 Q2 | 10.85 Million USD | -3.37% |
| 2001 Q1 | 11.23 Million USD | -6.69% |
| 2000 Q4 | 12.03 Million USD | 7.12% |
| 2000 Q1 | 12.28 Million USD | 0.0% |
| 2000 FY | 12.03 Million USD | -6.28% |
| 2000 Q2 | 12.16 Million USD | -0.98% |
| 2000 Q3 | 11.23 Million USD | -7.66% |
| 1999 FY | 12.84 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -3070.184% |
| BrainsWay Ltd. | 239 Thousand USD | -478770.293% |
| Cerus Corporation | 59.79 Million USD | -1814.008% |
| Envoy Medical, Inc. | 404 Thousand USD | -283192.079% |
| electroCore, Inc. | 537 Thousand USD | -213028.492% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -9537400.0% |
| IceCure Medical Ltd | 376 Thousand USD | -304288.298% |
| Inogen, Inc. | 18.27 Million USD | -6164.368% |
| OrthoPediatrics Corp. | 13.45 Million USD | -8403.604% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -575025.628% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -314561.667% |
| MaxCyte, Inc. | 17.96 Million USD | -6269.303% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -2070119.232% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | -1129.231% |
| PAVmed Inc | 2.96 Million USD | -38565.541% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -18318.088% |
| RxSight, Inc. | 1.21 Million USD | -94408.671% |
| Sight Sciences, Inc. | 31.7 Million USD | -3509.499% |
| SI-BONE, Inc. | 36.06 Million USD | -3073.437% |
| TELA Bio, Inc. | 40.51 Million USD | -2724.88% |
| Treace Medical Concepts, Inc. | 53 Million USD | -2059.108% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -75146.548% |
| Acutus Medical, Inc. | 32.65 Million USD | -3404.93% |
| Talis Biomedical Corporation | 16.78 Million USD | -6718.182% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -28194.19% |
| CVRx, Inc. | 30.38 Million USD | -3667.033% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -112444.62% |
| Bioventus Inc. | 366.99 Million USD | -211.855% |
| Venus Concept Inc. | 70.79 Million USD | -1516.754% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -91901.608% |
| LivaNova PLC | 568.54 Million USD | -101.304% |
| 908 Devices Inc. | 3.92 Million USD | -29029.55% |
| Alphatec Holdings, Inc. | 511.03 Million USD | -123.957% |
| Nemaura Medical Inc. | 3.08 Million USD | -36967.013% |
| NeuroPace, Inc. | 56.95 Million USD | -1909.516% |
| LENSAR, Inc. | 1.75 Million USD | -65300.0% |
| Apyx Medical Corporation | 33.18 Million USD | -3348.847% |
| Cutera, Inc. | 418.69 Million USD | -173.349% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -7507.684% |
| BioSig Technologies, Inc. | 103 Thousand USD | -1111065.049% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -4154.014% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -11403.669% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 22.93% |
| Axonics, Inc. | 25.84 Million USD | -4329.18% |
| Outset Medical, Inc. | 134.59 Million USD | -750.329% |
| IRIDEX Corporation | 1.75 Million USD | -65262.65% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -2129.299% |
| IRadimed Corporation | 1.61 Million USD | -70763.363% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -650184.091% |
| INVO Bioscience, Inc. | 6.77 Million USD | -16790.279% |
| Telesis Bio, Inc. | 5.26 Million USD | -21621.389% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -19066.71% |
| Varex Imaging Corporation | 464.2 Million USD | -146.553% |
| Quipt Home Medical Corp. | 60.82 Million USD | -1781.749% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -194542.857% |
| Pulmonx Corporation | 35.08 Million USD | -3161.706% |
| Dynatronics Corporation | 3.25 Million USD | -35023.76% |
| Modular Medical, Inc. | 817 Thousand USD | -139985.679% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -757847.02% |
| Semler Scientific, Inc. | 70 Thousand USD | -1634900.0% |
| InMode Ltd. | 6.61 Million USD | -17206.82% |
| Cytosorbents Corporation | 2.54 Million USD | -44908.429% |
| DexCom, Inc. | 2.57 Billion USD | 55.517% |
| Align Technology, Inc. | 96.96 Million USD | -1080.286% |
| Viveve Medical, Inc. | 5.12 Million USD | -22236.066% |
| ZimVie Inc. | 508.79 Million USD | -124.942% |
| Movano Inc. | 15.00 USD | -7629999900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -6214.483% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | -187.125% |
| Profound Medical Corp. | 4.97 Million USD | -22907.717% |
| Insulet Corporation | 1.36 Billion USD | 16.24% |
| enVVeno Medical Corporation | 1.06 Million USD | -107465.789% |
| Surmodics, Inc. | 29.4 Million USD | -3792.195% |
| iCAD, Inc. | 273 Thousand USD | -419130.769% |
| Nuwellis, Inc. | 221 Thousand USD | -517773.303% |
| Biotricity, Inc. | 10.85 Million USD | -10442.719% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -3174.678% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -176044.4% |
| InspireMD, Inc. | 1.03 Million USD | -110160.116% |
| PAVmed Inc. | 2.96 Million USD | -38565.541% |
| BIOLASE, Inc. | 13.98 Million USD | -8083.768% |
| Beyond Air, Inc. | 14.72 Million USD | -7674.608% |
| FONAR Corporation | 37.92 Million USD | -2917.448% |
| AxoGen, Inc. | 46.6 Million USD | -2355.85% |
| Vivani Medical, Inc. | 19.31 Million USD | -5826.06% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -2465.453% |
| Inari Medical, Inc. | 30.35 Million USD | -3670.384% |
| UFP Technologies, Inc. | 28 Million USD | -3987.5% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -263582.337% |
| Tenon Medical, Inc. | 428 Thousand USD | -267306.542% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -114121.557% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -53078.637% |
| AdaptHealth Corp. | 2.09 Billion USD | 45.36% |
| Sintx Technologies, Inc. | 3.68 Million USD | -30941.497% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -2974.712% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -194542.857% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -191930.201% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | -28.272% |
| TransMedics Group, Inc. | 506.2 Million USD | -126.095% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -188450.247% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -1237397.973% |
| Hyperfine, Inc. | 64 Thousand USD | -1788181.25% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | -506.393% |
| Biomerica, Inc. | 459 Thousand USD | -249246.405% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -254525.87% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -602309.639% |
| Silk Road Medical, Inc | 75.62 Million USD | -1413.368% |